Eliezer M Van Allen

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Eliezer M Van Allen

Nov 29, 2024, 15:37 | Insight

Giuseppe Tarantino: Genomic Heterogeneity and Ploidy predict resistance to Anti-PD-1 Therapy in Metastatic Melanoma

Giuseppe Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared on LinkedIn: "Excited to share our…

Oct 7, 2024, 17:05 | Blog

CRISPR-based mouse model for VHL-deficient clear cell kidney cancer shows promise, suggested by Yüksel Ürün

Yüksel Ürün shared an article by Laura A Stransky on X: "A new CRISPR-based mouse…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023